Physician profile
Irwin C Steinberg
NPI 1972585198
$1,421.25
in general payments reported to CMS, 2019-2025
11 companies · $63.10 in 2025
The $63.10 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.30 · 2020: $945 · 2021: $220 · 2022: $32.43 · 2023: $19.27 · 2024: $88.96 · 2025: $63.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $152 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.06 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $1,059.95 | 2020-2021 | |
| Abbvie INC. | $125.45 | 2019-2021 | |
| Hologic Sales and Service, LLC | $66.83 | 2024-2025 | Aptima |
| Pfizer INC. | $36.60 | 2022-2023 | |
| Baxter Healthcare | $26.13 | 2025 | Perclot |
| Coopersurgical, INC. | $22.02 | 2024 | Summit Doppler |
| Evofem Biosciences, INC. | $20.00 | 2024 | |
| Therapeuticsmd, INC. | $17.84 | 2019 | |
| Amgen INC. | $17.08 | 2024 | Evenity, Prolia |
| Myovant Sciences INC. | $15.10 | 2022 | |
| Minerva Surgical, INC | $14.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irwin Steinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.